The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 22, 2015

Filed:

Aug. 10, 2007
Applicants:

Kyung Aih Kang, Louisville, KY (US);

Stephen Peiper, Philadelphia, PA (US);

Inventors:

Kyung Aih Kang, Louisville, KY (US);

Stephen Peiper, Philadelphia, PA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 33/68 (2006.01); G01N 33/86 (2006.01); G01N 33/552 (2006.01); C07K 16/36 (2006.01); B01L 3/00 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6878 (2013.01); B01L 3/502715 (2013.01); C07K 16/36 (2013.01); G01N 33/86 (2013.01); C07K 2317/33 (2013.01); G01N 2333/7456 (2013.01); G01N 2800/224 (2013.01);
Abstract

A method for generating antibodies preferable to either a normal protein and a mutated form of the normal protein, respectively, where a mutation associated with the mutated form includes either a single point mutation or a small number of point mutations where the method includes creating first and second antigenic peptides of a predetermined length corresponding respectively to common regions of the normal target protein and the mutated form, where the common regions are identical to one another except for the point mutation of the mutated form, obtaining first and second antibodies by multiplying the first and second antigenic peptides via hybridoma methods, and identifying the respective affinities of the first and second antibodies for the normal target protein and the mutated form. Also included are methods of using the first and second antibodies to detect and quantify respective amounts of a normal target protein and a mutated form of the target protein. Also included are immunological sensors the include the first and second antibodies for determining the presence and quantity of normal target proteins and mutant forms of the normal target proteins.


Find Patent Forward Citations

Loading…